Clinical trial
Alpha-Bisabolol Gel With Antihistamine Action
NCT05022108 is registered in ClinicalTrials.gov with Universidade do Vale do Sapucai as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Alpha-Bisabolol Gel With Antihistamine Action
- Lead sponsor
- Universidade do Vale do Sapucai
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- April 1, 2020
- Completion date
- December 20, 2020
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.